Home / Health / Bone Health Crisis: India Faces Growing Osteoporosis Burden
Bone Health Crisis: India Faces Growing Osteoporosis Burden
27 Oct
Summary
- Osteoporosis affects 230 million Indians aged 50+, with women nearly 80% of cases.
- Osteoporosis strikes 10-20 years earlier in Indians than Western populations.
- Biosimilars could improve access and affordability of vital osteoporosis treatments.
As the global population ages, the burden of osteoporosis is escalating, particularly in emerging economies. In India, this challenge is substantial, with an estimated 230 million individuals aged 50 and above experiencing osteopenia. Osteoporosis affects a significant portion of this demographic, with women accounting for nearly 80% of the estimated 61 million cases.
A critical aspect of the Indian context is that osteoporosis tends to develop 10 to 20 years earlier compared to Western populations. This accelerated onset contributes to a high fracture burden, with over 4.5 million women over 60 suffering from vertebral fractures annually, and more than 250,000 hip fractures occurring each year.
Access to effective treatments remains a hurdle, as older therapies often face challenges with adherence due to side effects and dosing schedules. Biologic therapies have expanded options, and biosimilars are emerging as key solutions. These highly similar medicines can offer greater affordability, potentially improving access to necessary care.
By enhancing affordability and access, biosimilars can support healthcare systems in providing timely and appropriate treatment. Building confidence in biosimilar use through education and scientific exchange is vital. This approach, combined with good nutrition, physical activity, and early risk assessment, forms a comprehensive strategy to prevent fractures and maintain mobility and independence.
